Loading clinical trials...
Loading clinical trials...
This study will compare two approaches to cognitive rehabilitation in adults with long COVID with persistent, mild to moderate, cognitive impairment. One approach will feature (A) web-based computer "...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University of Alabama at Birmingham
Collaborators
NCT06347315 · Mild Cognitive Impairment
NCT07652775 · Mild Cognitive Impairment (MCI), Depressive Symptoms
NCT05877196 · Mild Cognitive Impairment, Alzheimer Disease, and more
NCT04240561 · Hearing Loss, Sensorineural, Dementia of Alzheimer Type, and more
NCT07441915 · Parkinson's Disease, Mild Cognitive Impairment
University of Alabama at Birmingham
Birmingham, Alabama
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions